Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,220 | -19,410 | -16,220 | -11,490 | -3,740 |
| Depreciation Amortization | 430 | 7,250 | 6,820 | 6,380 | 1,710 |
| Accounts payable and accrued liabilities | N/A | 26 | N/A | N/A | N/A |
| Other Working Capital | 20 | -420 | -170 | 10 | -340 |
| Other Operating Activity | 490 | 6,344 | 5,010 | 1,980 | 460 |
| Operating Cash Flow | $-1,280 | $-6,210 | $-4,560 | $-3,120 | $-1,910 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -90 | -250 | -70 | -70 | -20 |
| Other Investing Activity | -120 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-210 | $-250 | $-70 | $-70 | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,897 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 5,346 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -63 | 8,140 | 7,470 | 2,790 |
| Financing Cash Flow | $0 | $8,180 | $8,140 | $7,470 | $2,790 |
| Beginning Cash Position | 2,560 | 850 | 850 | 850 | 850 |
| End Cash Position | 1,060 | 2,560 | 4,350 | 5,110 | 1,710 |
| Net Cash Flow | $-1,500 | $1,700 | $3,500 | $4,260 | $850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,280 | -6,210 | -4,560 | -3,120 | -1,910 |
| Capital Expenditure | N/A | -259 | N/A | N/A | N/A |
| Free Cash Flow | -1,280 | -6,469 | -4,560 | -3,120 | -1,910 |